Header cover image

Belgian Pharmaceuticals & Biotech Sustainable Track Record

Results

1

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

argenx

Market Cap: €53.5b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€870.00

7D

16.2%

1Y

55.6%